In renal cancer cells including RCC4, 24hr treatment with rapamycin or BEZ235 was shown to activate MEK-ERK signaling, and MEK inhibition sensitised to low nM though not 1 μM BEZ235 [62]. The gene discussed is MAP2K7; the disease is renal carcinoma.